Annual report pursuant to Section 13 and 15(d)

Property Portfolio

v3.19.1
Property Portfolio
12 Months Ended
Dec. 31, 2018
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment Disclosure [Text Block]
Note 3 – Property Portfolio
 
Summary of Properties Acquired During the Year Ended December 31, 2018
 
During the year ended December 31, 2018, the Company completed 14 acquisitions. Substantially all of the fair value of the acquisitions was concentrated in a single identifiable asset or group of similar identifiable assets and, therefore, all of the acquisitions represent asset acquisitions under the guidance provided by ASU 2017-01. Accordingly, transaction costs for these acquisitions were capitalized.
 
A rollforward of the gross investment in land, building and improvements as of December 31, 2018, resulting from these acquisitions is as follows:
 
   
Land
   
Building
   
Site & Tenant
Improvements
   
Acquired Lease
Intangibles
   
Gross Investment in
Real Estate
 
Balances as of January 1, 2018   $ 42,701     $ 384,338     $ 12,818     $ 31,650     $ 471,507  
Facility Acquired – Date Acquired:                                        
   Moline / Silvis – 1/24/18     -       4,895       1,216       989       7,100  
   Freemont – 2/9/18     162       8,335       -       -       8,497  
   Gainesville – 2/23/18     625       9,885       -       -       10,510  
   Dallas – 3/1/18     6,272       17,012       -       -       23,284  
   Orlando – 3/22/18     2,543       11,720       756       1,395       16,414  
   Belpre – 4/19/18     3,025       50,526       3,966       7,166       64,683  
   McAllen – 7/3/18     1,099       4,296       -       -       5,395  
   Derby – 8/3/18     412       2,496       243       453       3,604  
   Bountiful – 10/12/18     720       4,185       -       -       4,905  
   Cincinnati – 10/30/18     1,745       1,336       553       492       4,126  
   Melbourne – 11/16/18     645       5,950       117       1,007       7,719  
   Southern IL – 11/30/18     1,830       12,660       -       -       14,490  
   Vernon – 12/19/18     1,166       9,929       -       -       11,095  
   Corona – 12/31/18     1,601       14,689       -       -       16,290  
Tenant improvements
(1)
    -       -       2,568       -       2,568  
Total Additions
(2)
:
    21,845       157,914       9,419       11,502       200,680  
Disposition of Great Bend – 12/20/18     (836 )     (23,801 )     -       -       (24,637 )
Balances as of December 31, 2018   $ 63,710     $ 518,451     $ 22,237     $ 43,152     $ 647,550  
(1)
Represents tenant improvements that were completed and placed in service during the year ended December 31, 2018 related to the Silvis and Sherman facilities that were acquired in January 2018 and June 2017, respectively. Of the $2,568, there were $2,535 of costs recorded as construction-in-process within the “Other Assets” line item in the Company’s Consolidated Balance Sheet when incurred and reclassified to investment in real estate once completed, and $33 of costs that were incurred and paid in cash and recorded directly as tenant improvements.
(2)
The Belpre, Southern IL, and Corona acquisitions included an aggregate of $16,362 of OP Units issued as part of the total consideration for those transactions. As indicated in footnote (1) above, $2,535 of completed construction-in-process costs were reclassified to investment in real estate during the year ended December 31, 2018. Additionally, an aggregate of $946 of intangible liabilities were acquired from the acquisitions that occurred during the year ended December 31, 2018. Accordingly, the total addition to gross investment in real estate funded with cash was $180,837.
 
Depreciation expense was $13,644, $7,929, and $2,335 for the years ended December 31, 2018, 2017, and 2016, respectively.
 
As of December 31, 2018, the Company had aggregate capital improvement commitments to improve or expand existing tenant space of $17 million. Many of these allowances are subject to contingencies that make it difficult to predict when such allowances will be utilized, if at all. In accordance with the terms of a number of the Company’s leases, tenant improvement obligations in 2019 could total approximately $9 million.
 
The following is a summary of the 14 acquisitions completed during the year ended December 31, 2018.
 
Moline / Silvis Facilities
 
Moline Facility
 
-
 
On January 24, 2018, the Company purchased a medical office building located in Moline, Illinois, which included the seller’s interest, as ground lessee, in an existing ground lease. The ground lease has approximately 10 years remaining in the initial term, with 12 consecutive five-year renewal options. Upon the closing of this acquisition, the Company assumed two subleases: one sublease with Fresenius Medical Care Quad Cities, LLC (“Fresenius”) with approximately 13 years remaining in the initial term, with three consecutive five-year renewal options; and one sublease with Quad Cities Nephrology Associates, P.L.C. with approximately 15 years remaining in the initial term, with three consecutive five-year renewal options. 
 
Silvis Facility -
 
On January 24, 2018, the Company purchased a medical office building located in Silvis, Illinois from the same seller as the Moline facility, which included the seller’s interest, as ground lessee, in an existing ground lease. The ground lease has approximately 67 years remaining in the initial term, with no renewal options. Upon the closing of this acquisition, the Company assumed one sublease with Fresenius with approximately 13 years remaining in the initial term, with three consecutive five-year renewal options.
 
The aggregate purchase price for the Moline/Silvis facilities was $6.9 million. The following table presents the details of the tangible and intangible assets acquired and liabilities assumed for this acquisition:
 
Site improvements   $ 249  
Building and tenant improvements     5,862  
In-place leases     343  
Above market ground lease intangibles     219  
Leasing costs     427  
Below market lease intangibles     (229 )
   Total purchase price   $ 6,871  
  
Fremont Facility
 
-
 
On February 9, 2018, the Company purchased a medical office building located in Fremont, Ohio for a purchase price of $8.5 million. Upon the closing of this acquisition, the Company entered into a new 12-year lease with Northern Ohio Medical Specialists, LLC (NOMS) with four consecutive five-year renewal options.
 
Gainesville Facility
 
-
 
On February 23, 2018, the Company purchased a medical office building and ambulatory surgery center located in Gainesville, Georgia for a purchase price of $10.5 million. Upon the closing of this acquisition, the Company entered into a new 12-year lease with SCP Eye Care Services, LLC with four consecutive five-year renewal options.
 
Dallas Facility
 
-
 
On March 1, 2018, the Company purchased a hospital, a three-story parking garage, and land all located in Dallas, Texas for an aggregate purchase price of $23.3 million. In addition to the hospital and the parking garage, the land underlays two medical office buildings that are not owned by the Company, each of which is ground leased to the hospital. Upon the closing of this acquisition, the Company entered into two leases with Pipeline East Dallas, LLC, with one lease relating to the hospital and the other lease relating to the underlying land and parking garage.
 
Orlando Facilities
 – On March 22, 2018, the Company purchased five medical office buildings located in Orlando, Florida from five affiliated sellers for an aggregate purchase price of $16.4 million. Upon the closing of this acquisition, the Company assumed five existing leases with Orlando Health, Inc. One lease has approximately one year remaining in its initial term, with one 10-year renewal option; one lease has approximately six years remaining in its initial term, with three consecutive five-year renewal options; one lease has approximately six years remaining in its initial term, with four consecutive five-year renewal options; one lease has approximately six years remaining in its initial term, with three consecutive five-year renewal options; and one lease was amended at closing to extend the remaining term to five years with four consecutive five-year renewal options. The following table presents the details of the tangible and intangible assets acquired and liabilities assumed
:
 
Land and site improvements   $ 3,075  
Building and tenant improvements     11,944  
In-place leases     808  
Above market lease intangibles     229  
Leasing costs     358  
Below market lease intangibles     (10 )
   Total purchase price   $ 16,404  
 
 
Belpre Portfolio
 
- On April 19, 2018, the Company purchased a portfolio of four medical office buildings and a right of first refusal to purchase a fifth, yet to be built, medical office building on the same campus, for an aggregate purchase price of $64.1 million. Upon the closing of the acquisition the Company assumed the existing leases with Marietta Memorial Hospital, a subsidiary of Memorial Health System and such leases had a weighted average remaining lease term of approximately 11.35 years, each with three consecutive five-year tenant renewal options. The following table presents the details of the tangible and intangible assets acquired and liabilities assumed:
 
Land and site improvements   $ 3,997  
Building and tenant improvements     53,520  
In-place leases     2,660  
Above market lease intangibles     2,527  
Leasing costs     1,979  
Below market lease intangibles     (632 )
   Total purchase price   $ 64,051  
  
McAllen Facility
 
- On July 3, 2018, the Company purchased a medical office building (and adjacent condominium) located in McAllen, Texas for a purchase price of $5.4 million. Upon the closing of this acquisition, the Company entered into a new 11-year lease with Valley Ear, Nose, and Throat Specialists, PA, with two consecutive 10-year renewal options.
 
Derby Facility
 
-
 
On August 3, 2018, the Company purchased a medical office building located in Derby, Kansas for a purchase price of $3.6 million. Upon the closing of this acquisition, the Company assumed the existing lease with Rock Surgery Center, LLC. The lease has approximately nine years remaining in its initial term, with one five-year tenant renewal option. The following table presents the details of the tangible and intangible assets acquired and liabilities assumed:
 
Land and site improvements   $ 566  
Building and tenant improvements     2,585  
In-place leases     299  
Leasing costs     154  
Below market lease intangibles     (23 )
   Total purchase price   $ 3,581  
  
Bountiful Facility
 
- On October 12, 2018, the Company purchased a medical office building located in Bountiful, Utah for a purchase price of $4.9 million. Upon the closing of this acquisition, the Company entered into a lease with Ryan K. Anderson, D.P.M., P.C., a professional corporation doing business as Foot and Ankle Specialists of Utah. The lease has an initial term of 15 years, with two consecutive 15 year extension options.
 
Cincinnati Facility
 
-
 
On October 30, 2018, the Company purchased a medical office building located in Cincinnati, Ohio, for a purchase price of $4.0 million. Upon the closing of the acquisition, the Company assumed the existing leases with TriHealth, Inc., as tenant as follows: (i) the lease of Unit A with seven years remaining in the initial term and three consecutive five year renewal options; (ii) the lease of Unit B with eight years remaining in the initial term and three consecutive five year renewal options; and (iii) the lease of Unit C with seven years remaining in the initial term and three consecutive five year renewal options. The following table presents the details of the tangible and intangible assets acquired and liabilities assumed:
 
Land and site improvements   $ 1,824  
Building and tenant improvements     1,810  
In-place leases     236  
Above market lease intangibles     131  
Leasing costs     125  
Below market lease intangibles     (52 )
   Total purchase price   $ 4,074  
  
Melbourne Facility
 
-
 
On November 16, 2018, the Company purchased a medical office building located in Melbourne, Florida for a purchase price of $7.7 million. Upon the closing of the acquisition, the Company assumed the existing lease with Brevard Radiation Oncology, LLC, as tenant. The lease has five years remaining in the initial term, with two consecutive five year renewal options. The following table presents the details of the tangible and intangible assets acquired and liabilities assumed:
 
Land and site improvements   $ 732  
Building and tenant improvements     5,980  
In-place leases     346  
Above market lease intangibles     504  
Leasing costs     157  
   Total purchase price   $ 7,719  
  
Southern IL Facilities
 
- On November 30, 2018, the Company purchased six buildings at four locations in Southern Illinois, for an aggregate purchase price of $14.5 million. Details regarding the six buildings and the Company’s tenants and lease terms are as follows:
 
Two of the six buildings are medical office buildings located in Shiloh, Illinois. Upon the closing of the acquisition, the Company assumed two leases at one of the buildings located in Shiloh as follows: (i) a lease of Suite 1 with SSM Health Care St. Louis with approximately seven years remaining in the initial term and two consecutive five year renewal options; and (ii) a lease of Suite 2 with Metro East Dermatology and Skin Cancer Center, LLC with approximately one year remaining in the initial term and consecutive one year renewal options unless the Company or the tenant terminates the lease in writing prior to the expiration of the term. Upon the closing of the acquisition of the second building located in Shiloh, the Company assumed a lease of Suite 2 with Quest Diagnostics Clinical Laboratories, Inc. with approximately nine months remaining in the initial term and two consecutive five year renewal options. The Company entered into a new lease of Suite 1 with Heartland Women’s Healthcare IL, P.C. having an initial term of 12 years and two consecutive five year renewal options. The tenant’s obligations under this lease are guaranteed by USA OBGYN Management, LLC.
 
One of the six buildings is a mixed-use, commercial building located in Carbondale, Illinois. At the time of the closing of the acquisition, portions of the building were leased to six different tenants for medical, general office and restaurant uses. Simultaneously with the closing, the Company entered into a lease with Seller’s affiliate, Heartland Women’s Healthcare, Ltd. (the “Master Tenant”) having an initial term of 12 years and two consecutive five year renewal options. For the first five years of the initial term, the Master Tenant master leases the entire building (with the leases existing at the time of closing being converted to subleases between the Master Tenant and such tenants). For the last seven years of the initial term and any renewal terms, the premises is reduced to 6,592 rentable square feet, and any other leases then in effect are assigned to the Company and become direct leases between the Company and the tenants under those leases. The Master Tenant’s obligations under this lease are guaranteed by USA OBGYN Management, LLC.
 
One of the six buildings is a medical office building located in Marion, Illinois. Upon the closing of the acquisition, the Company entered into a lease with Heartland Women’s Healthcare, Ltd. for the entire building, having an initial term of 12 years and two consecutive five year renewal options. The tenant’s obligations under this lease are guaranteed by USA OBGYN Management, LLC.
 
Two of the six buildings are medical office buildings located in Mount Vernon, Illinois. Upon the closing of the acquisition, the Company entered into a lease with Heartland Women’s Healthcare, Ltd. for both buildings, having an initial term of 12 years and two consecutive five year renewal options. The tenant’s obligations under this lease are guaranteed by USA OBGYN Management, LLC.
 
Vernon Facilities
 
-
 
On December 19, 2018, the Company purchased two medical office buildings located in Vernon, Connecticut for a total purchase price of $10.9 million. Upon the closing of the acquisition, the Company leased the facilities to Prospect ECHN, Inc. One lease has an initial term of 15 years with two consecutive 10-year extension option, and the other lease has an initial term of 12 years with two consecutive 10-year extension options.
 
Corona Facility
 
-
 
On December 31, 2018, the Company purchased a medical office building located in Corona, California for a purchase price of $17.2 million. Upon the closing of the acquisition, the Company entered into a lease with Citrus Valley Medical Associates, Inc. The lease has an initial term of 12 years with no renewal option.
 
Disposition
 
On December 20, 2018, the Company disposed of the Great Bend Regional Hospital receiving gross proceeds of $32.5 million, resulting in a gain of approximately $7.7 million. After commissions and expenses paid, net proceeds received were $31.6 million.
 
Summary of Properties Acquired During the Year Ended December 31, 2017
 
During the year ended December 31, 2017, the Company completed 23 acquisitions. A rollforward of the gross investment in land, building and improvements as of December 31, 2017, resulting from these acquisitions is as follows:
 
   
Land
   
Building
   
Site & Tenant
Improvements
   
Acquired Lease
Intangibles
   
Gross Investment in
Real Estate
 
Balances as of January 1, 2017   $ 17,786     $ 179,253     $ 2,651     $ 7,187     $ 206,877  
Facility Acquired – Date Acquired:                                        
Cape Coral – 1/10/17     352       7,017       -       -       7,369  
Lewisburg – 1/12/17     471       5,819       505       505       7,300  
Las Cruces – 2/1/17     396       4,618       -       -       5,014  
Prescott – 2/9/17     791       3,821       -       -       4,612  
Clermont – 3/1/17     -       4,361       206       868       5,435  
Sandusky – 3/10/17     409       3,998       -       -       4,407  
Great Bend – 3/31/17     837       23,801       -       -       24,638  
Oklahoma City – 3/31/17     2,087       37,714       1,876       7,823       49,500  
Sandusky – 4/21/17     98       978       -       -       1,076  
Brockport – 6/27/17     413       6,885       492       1,295       9,085  
Flower Mound – 6/27/17     581       2,922       382       407       4,292  
Sherman facility – 6/30/17     1,601       25,011       -       -       26,612  
Sandusky facility – 8/15/17     56       1,215       -       -       1,271  
Lubbock facility – 8/18/17     1,303       5,042       947       908       8,200  
Germantown – 8/30/17     2,700       8,078       657       4,505       15,940  
Austin – 9/25/17     6,958       28,508       1,373       3,811       40,650  
Fort Worth – 11/10/17     1,487       3,334       643       786       6,250  
Albertville – 11/10/17     866       3,486       1,246       1,202       6,800  
Moline – 11/10/17     722       8,175       1,194       1,916       12,007  
Lee’s Summit – 12/18/17     428       2,426       646       437       3,937  
Amarillo – 12/20/17     1,437       7,254       -       -       8,691  
Wyomissing – 12/21/17     487       5,250       -       -       5,737  
Saint George – 12/22/17     435       5,372       -       -       5,807  
Total Additions
(1)
:
    24,915       205,085       10,167       24,463       264,630  
Balances as of December 31, 2017   $ 42,701     $ 384,338     $ 12,818     $ 31,650     $ 471,507  
 
(1)
The Lubbock and Moline facility acquisitions included an aggregate of approximately $11,300 of OP Units issued as part of the total consideration. Additionally, an aggregate of $1,110 of intangible liabilities were acquired from the acquisitions that occurred during the year ended December 31, 2017, resulting in total gross investments funded using cash of $252,220
 
As of December 31, 2017, the Company had tenant improvement allowances of approximately $10 million. These tenant improvement allowances are subject to contingencies that make it difficult to predict when such allowances will be utilized, if at all.
 
The following acquisitions completed during the year ended December 31, 2017 were accounted for as business combinations under ASC Topic 805.
 
Lewisburg Facility -
On January 12, 2017, the Company purchased a medical office building located in Lewisburg, Pennsylvania, for a purchase price of $7.3 million. Upon the closing of the transaction, the Company assumed two leases. Both leases expire in 2023 and have two five-year tenant renewal options. The following table presents the preliminary purchase price allocation
:
 
Land and site improvements   $ 681  
Building and tenant improvements     6,114  
In place leases     373  
Leasing costs     132  
Total purchase price   $ 7,300  
 
Clermont Facility -
 
On March 1, 2017, the Company purchased the seller’s interest, as ground lessee, in certain real property and a medical building located in Clermont, Florida, for a purchase price of $5.2 million. The ground lease has a remaining term of approximately 71 years. Upon closing of this acquisition, the Company assumed four subleases: two subleases with South Lake Hospital, Inc. each expiring in 2024, each with two, five-year tenant renewal options, one sublease with Orlando Health, Inc. expiring in 2021 with two, five-year renewal options, and one sublease with Vascular Specialists of Central Florida expiring in 2024 with two, five-year renewal options. The following table presents the preliminary purchase price allocation:
 
Site improvements   $ 145  
Building and tenant improvements     4,422  
In place leases     255  
Above market lease intangibles     488  
Leasing costs     125  
Below market lease intangibles     (210 )
Total purchase price   $ 5,225  
 
Oklahoma City Facilities -
 
On March 31, 2017, the Company purchased a surgical hospital, a physical therapy center (together with the hospital, “OCOM South”), and an outpatient ambulatory surgery center (“OCOM North”) located in Oklahoma City, Oklahoma for an aggregate purchase price of $49.5 million. The purchase price consisted of $44.4 million for OCOM South and $5.1 million for OCOM North.
 
Upon closing of the acquisition of OCOM South, the Company entered into a new lease (the “Master Lease”) with the seller that expires in 2022 and assumed, as a sublease to the Master Lease, the existing absolute triple-net lease (the “OCOM South Lease”) with Oklahoma Center for Orthopedic & Multi-Specialty Surgery, LLC (“OCOM”) with a remaining term expiring in 2034, subject to three consecutive five-year tenant renewal options. Upon the expiration of the Master Lease, the OCOM South Lease will become a direct lease with the Company. A portion of the rent under the OCOM South sublease is guaranteed by United Surgical Partners International, Inc. and INTEGRIS Health, Inc.
 
Upon closing of the acquisition of OCOM North, the Company assumed the existing lease. The lease has a remaining term expiring in 2022, with two consecutive five-year tenant renewal options. The following table presents the preliminary purchase price allocation:
 
Land and site improvements   $ 2,953  
Building and tenant improvements     38,724  
Above market lease intangibles     759  
In place leases     4,392  
Leasing costs     2,672  
Total purchase price   $ 49,500  
 
Brockport Facility -
 
On June 27, 2017, the Company purchased a medical office building located in Brockport, New York for a purchase price of $8.7 million. Upon the closing of this acquisition, the Company assumed the existing lease with The Unity Hospital of Rochester. The lease has a remaining term expiring 2030, with three consecutive five-year tenant renewal options. The following table presents the preliminary purchase price allocation:
 
 
Land and site improvements   $ 693  
Building and tenant improvements     7,097  
In place leases     841  
Leasing costs     454  
Below market lease intangible     (415 )
Total purchase price   $ 8,670  
 
Flower Mound Facility -
 
On June 27, 2017, the Company purchased a medical office building located in Flower Mound, Texas for a purchase price of $4.1 million. Upon the closing of this acquisition, the Company assumed the existing lease with Lone Star Endoscopy Center, LLC. The lease has a remaining term expiring in 2026, with two consecutive five-year tenant renewal options. The following table presents the preliminary purchase price allocation:
 
Land and site improvements   $ 730  
Building and tenant improvements     3,155  
In place leases     222  
Leasing costs     185  
Below market lease intangible     (242 )
Total purchase price   $ 4,050  
 
Lubbock Facility -
 
On August 18, 2017, the Company purchased a medical office building located in Lubbock, Texas for a purchase price of $8.2 million. Upon the closing of this acquisition, the Company entered into a new lease with Lubbock Heart Hospital, LLC. The lease has a remaining term expiring 2029, with two consecutive five-year tenant renewal options. The following table presents the preliminary purchase price allocation:
 
Land and site improvements   $ 1,567  
Building and tenant improvements     5,725  
In-place leases     414  
Leasing costs     494  
Total purchase price   $ 8,200  
 
Germantown Facility -
 
On August 30, 2017, the Company purchased a medical office building located in Germantown, Tennessee for a purchase price of $15.9 million. Upon the closing of this acquisition, the Company assumed three existing leases with the Urology Center of the South. The leases have remaining terms of approximately seven years and each lease has two consecutive five-year tenant renewal options. The following table presents the preliminary purchase price allocation:
 
Land and site improvements   $ 3,050  
Building and tenant improvements     8,385  
Above market lease intangible     3,284  
In-place leases     587  
Leasing costs     634  
Total purchase price   $ 15,940  
 
Austin Facility -
 
On September 25, 2017, the Company purchased a rehabilitation hospital located in Austin, Texas and approximately 1.27 acres of land adjacent to the hospital that has been planned to accommodate the development of a long-term, acute care hospital for an aggregate purchase price of $40.7 million. Upon the closing of the acquisition of the facility, the Company assumed the existing lease with CTRH, LLC. The lease has a remaining term of approximately 9.6 years, with four consecutive five-year tenant renewal options, and 80% of the lease payments are guaranteed by Kindred Healthcare. The following table presents the preliminary purchase price allocation:
 
Land and site improvements   $ 7,223  
Building and tenant improvements     29,616  
Above market lease intangible     246  
In-place leases     1,680  
Leasing costs     1,885  
Total purchase price   $ 40,650  
 
Fort Worth Facility -
 
On November 10, 2017, the Company purchased a medical office building located in Fort Worth, Texas for a purchase price of $6.3 million. Upon the closing of the acquisition, the Company assumed the existing lease with Texas Digestive Disease Consultants, PLLC. The lease has a remaining term of approximately 10 years with two consecutive five year tenant renewal options. The following table presents the preliminary purchase price allocation:
 
Land and site improvements   $ 1,738  
Building and tenant improvements     3,726  
Above market lease intangible     126  
In-place leases     314  
Leasing costs     346  
Total purchase price   $ 6,250  
 
Albertville Facility -
 
On November 10, 2017, the Company purchased a medical office building located in Albertville, Minnesota for a purchase price of $6.8 million. Upon the closing of the acquisition, the Company assumed the existing lease with Stellis Health, P.A. The lease has a remaining term of approximately 11 years with two consecutive five-year extension options. The following table presents the preliminary purchase price allocation:
 
Land and site improvements   $ 1,154  
Building and tenant improvements     4,444  
Above market lease intangible     103  
In-place leases     802  
Leasing costs     297  
Total purchase price   $ 6,800  
 
Moline Facility -
 
On November 10, 2017, the Company purchased a medical office building located in Moline, Illinois for a purchase price of $11.9 million. Upon the closing of the acquisition, the Company assumed the existing leases with Heartland Clinic, LLC, RSC Illinois, LLC, and Valley Laboratories, L.L.C. Each lease has a remaining term of approximately 16 years with no tenant renewal options. The following table presents the preliminary purchase price allocation:
 
Land and site improvements   $ 854  
Building and tenant improvements     9,237  
Above market lease intangible     33  
In-place leases     1,050  
Leasing costs     833  
Below market lease intangible     (107 )
Total purchase price   $ 11,900  
 
Lee’s Summit Facility -
 
On December 18, 2017, the Company purchased a medical office building located in Lee’s Summit, Missouri for a purchase price of $3.8 million. Upon the closing of the acquisition, the Company assumed the existing lease with Prime Healthcare Services Blue Springs, LLC. The lease has remaining term of approximately seven years remaining in its initial term, with two three- year extension options. The following table presents the preliminary purchase price allocation:
 
Land and site improvements   $ 571  
Building and tenant improvements     2,929  
In-place leases     303  
Leasing costs     134  
Below market lease intangible     (137 )
Total purchase price   $ 3,800  
 
The following acquisitions completed during the year ended December 31, 2017 were accounted for as asset acquisitions:
 
Cape Coral Facility -
 
On January 10, 2017, the Company purchased a medical office building located in Cape Coral, Florida, for a purchase price of $7.3 million. Upon the closing of the acquisition, the Company entered into a new 10-year lease with The Sypert Institute, P.A. with three consecutive five-year tenant renewal options.
 
Las Cruces Facility -
 
On February 1, 2017, the Company purchased a medical office building located in Las Cruces, New Mexico for a purchase price of $5.0 million. Upon closing of this acquisition, the Company entered into a new 12-year lease with Las Cruces Orthopedic Associates with four consecutive five-year tenant renewal options.
 
Prescott Facility -
 
On February 9, 2017, the Company purchased a medical office building located in Prescott, Arizona, for a purchase price of $4.5 million. Upon the closing of this acquisition, the Company entered into a new 10-year lease with Thumb Butte Medical Center, PLLC with two consecutive seven-year renewal options.
 
Sandusky Facility -
 
On March 10, 2017, the Company purchased one, out of a total of seven, properties for a purchase price of approximately $4.3 million. Upon the closing of this acquisition, the Company entered into a new 11-year master lease with the Northern Ohio Medical Specialists (NOMS) with four consecutive five-year tenant renewal options.
 
Great Bend Facility -
 
On March 31, 2017, the Company purchased an acute-care hospital located in Great Bend, Kansas for a purchase price of $24.5 million. Upon the closing of the acquisition, the Company entered into a new 15-year lease with Great Bend Regional Hospital with two consecutive ten-year renewal options.
 
Sandusky Facility -
 
On April 21, 2017, the Company purchased a medical property (out of a total portfolio of seven medical properties) in Sandusky, Ohio for a purchase price of approximately $1.1 million. Upon the closing of this acquisition, the Company amended the existing master lease with NOMS to include the Sandusky facility
 
Sherman Facility -
 
On June 30, 2017, the Company purchased a rehabilitation hospital and long-term acute care facility located in Sherman, Texas for a purchase price of $26 million. Upon closing of this acquisition, the Company entered into a new 20-year lease with SDB Partners, LLC. with two consecutive 10-year tenant renewal options.
 
Sandusky Facility (Ballville Facility) -
 
On August 15, 2017, the Company purchased a medical office building located in Ballville, Ohio for a purchase price of $1.2 million. Upon the closing of this acquisition, the Company amended the existing master lease with NOMS to include the Ballville facility.
 
Amarillo Facility -
 
On December 20, 2017, the Company purchased a medical office building located in Amarillo, Texas for a purchase price of $8.7 million. Upon the closing of this acquisition, the Company entered into a new 12-year lease with Amarillo Bone & Joint Clinic PLLC. with two consecutive 10-year tenant renewal options.
 
Wyomissing Facility -
 
On December 21, 2017, the Company purchased a medical office building located in Wyomissing, Pennsylvania for a purchase price of $5.6 million. Upon the closing of this acquisition, the Company entered into a new 10-year lease with Berks-Schuylkill Respiratory Specialists, Ltd. with two consecutive five year tenant renewal options.
 
Saint George Facility -
 
On December 22, 2017, the Company purchased a medical office building located in St. George, Utah for a purchase price of $5.8 million. Upon the closing of this acquisition, the Company entered into a new 12-year lease with Jason A. Ahee, M.D. P.C. doing business as Zion Eye Institute with four consecutive five-year tenant renewal options.
 
Intangible Assets and Liabilities
 
The following is a summary of the carrying amount of intangible assets and liabilities as of December 31, 2018 and 2017:
 
   
As of December 31, 2018
 
   
Cost
   
Accumulated
Amortization
   
Net
 
Assets
                       
In-place leases   $ 21,753     $ (4,037 )   $ 17,716  
Above market ground lease     707       (28 )     679  
Above market leases     8,009       (1,096 )     6,913  
Leasing costs     12,683       (1,703 )     10,980  
    $ 43,152     $ (6,864 )   $ 36,288  
Liability
                       
Below market leases   $ 2,336     $ (308 )   $ 2,028  
 
   
As of December 31, 2017
 
   
Cost
   
Accumulated
Amortization
   
Net
 
Assets
                       
In-place leases   $ 17,061     $ (1,577 )   $ 15,484  
Above market ground lease     488       (6 )     482  
Above market leases     4,625       (220 )     4,405  
Leasing costs     9,476       (538 )     8,938  
    $ 31,650     $ (2,341 )   $ 29,309  
Liability
                       
Below market leases   $ 1,389     $ (98 )   $ 1,291  
 
The following is a summary of the acquired lease intangible amortization:
 
   
Year Ended December 31,
 
   
2018
   
2017
   
2016
 
Amortization expense related to in-place leases   $ 2,460     $ 1,542     $ 35  
Amortization expense related to leasing costs   $ 1,165     $ 530     $ 7  
Decrease in rental revenue related to above market ground lease   $ 22     $ 6     $ -  
Decrease in rental revenue related to above market leases   $ 876     $ 220     $ -  
Increase in rental revenue related to below market leases   $ (210 )   $ (97 )   $ (1 )
 
Future aggregate net amortization of the acquired lease intangible assets and liabilities as of December 31, 2018, is as follows:
 
   
Net Decrease
 

in Revenue
   
Increase in
 

Expense
 
2019   $ (772 )   $ 3,885  
2020     (721 )     3,831  
2021     (724 )     3,217  
2022     (725 )     2,908  
2023     (703 )     2,626  
Thereafter     (1,919 )     12,229  
Total   $ (5,564 )   $ 28,696  
 
For the year ended December 31, 2018, the weighted average amortization period for asset lease intangibles and liability lease intangibles are 7.11 years and 8.70 years, respectively.
 
Unaudited Pro Forma Financial Information
 
No acquisitions that occurred during 2018 qualified for treatment as a business combination and therefore pro forma information is not provided for acquisitions that occurred during the year ended December 31, 2018. The businesses acquired in 2017 and 2016 that were accounted for as business combinations were included in our results of operations from the dates of acquisition. The following table provides summary unaudited pro forma information as if the Company’s acquisitions during the years ended December 31, 2017 and 2016 that were accounted for as business combinations had occurred as of January 1, 2016:
 
   
Year Ended December 31,
 
   
2017
   
2016
 
   
(unaudited)
 
             
Revenue   $ 38,140     $ 28,559  
Net income (loss)   $ 1,828     $ (1,191 )
Net income (loss) attributable to common stockholders   $ 41     $ (1,191 )
Income (loss) attributable to common stockholders per share – basic and diluted   $ -     $ (0.13 )
Weighted average shares outstanding – basic and diluted   $ 19,617     $ 9,302